Shopping Cart 0
Cart Subtotal
USD 0

RegenxBio Inc (RGNX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

RegenxBio Inc (RGNX) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

RegenxBio Inc (RegenxBio), formerly ReGenX Biosciences LLC is a provider of therapeutics for various diseases. The company develops, commercializes and licenses recombinant adeno associated virus (AAV) gene therapy. Its products include AAV plasmids, AAV vector reporter systems and custom AAV vectors. RegenxBio employs its proprietary NAV technology platform, a gene delivery technology to develop product candidates. The company offers products for metabolic, muscle, hematologic, ocular and neurodegenerative disorders. Its products find application in the areas of gene therapy, gene modulation, protein therapeutics, genetic vaccines and protein screening. RegenxBio is headquartered in Rockville, Maryland, the US.

RegenxBio Inc Key Recent Developments

May 29,2018: REGENXBIO Names Alexandra Glucksmann As Board Director

May 15,2018: REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation

May 08,2018: REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights

Apr 23,2018: Groundbreaking Research for Inherited Retinal Diseases Funded by Foundation Fighting Blindness to be Showcased at ARVO

Mar 06,2018: REGENXBIO Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 About the Company 6

RegenxBio Inc Key Facts 6

RegenxBio Inc Key Employees 7

RegenxBio Inc Key Employee Biographies 8

RegenxBio Inc Major Products and Services 9

RegenxBio Inc History 10

RegenxBio Inc Company Statement 11

RegenxBio Inc Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2 Company Analysis 13

Company Overview 13

RegenxBio Inc Business Description 14

R&D Overview 14

RegenxBio Inc Corporate Strategy 15

RegenxBio Inc SWOT Analysis 16

SWOT Analysis Overview 16

RegenxBio Inc Strengths 16

RegenxBio Inc Weaknesses 17

RegenxBio Inc Opportunities 18

RegenxBio Inc Threats 19

RegenxBio Inc Key Competitors 20

Section 3 Company Financial Ratios 21

Financial Ratios Capital Market Ratios 21

Financial Ratios Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios Interim Ratios 25

Financial Ratios Ratio Charts 26

Section 4 Company's, Lifesciences Financial Deals and Alliances 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

RegenxBio Inc, Recent Deals Summary 29

Section 5 Company's Recent Developments 30

May 15, 2018: REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation 30

May 08, 2018: REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights 31

Apr 23, 2018: Groundbreaking Research for Inherited Retinal Diseases Funded by Foundation Fighting Blindness to be Showcased at ARVO 33

Mar 06, 2018: REGENXBIO Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Highlights 35

Jan 04, 2018: REGENXBIO Provides Year End 2017 Corporate Update 37

Nov 08, 2017: REGENXBIO Reports Third Quarter 2017 Financial Results and Recent Operational Highlights 40

Aug 08, 2017: REGENXBIO Reports Second Quarter 2017 Financial Results and Recent Operational Highlights 42

May 09, 2017: REGENXBIO Reports First Quarter 2017 Financial Results and Recent Operational Highlights 44

Mar 28, 2017: REGENXBIO Enhances and Expands Scientific Leadership 46

Mar 07, 2017: REGENXBIO Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Highlights 47

Section 6 Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

RegenxBio Inc, Performance Chart (2013 2017) 24

RegenxBio Inc, Ratio Charts 26

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28


List Of Table

List of Tables

RegenxBio Inc, Key Facts 6

RegenxBio Inc, Key Employees 7

RegenxBio Inc, Key Employee Biographies 8

RegenxBio Inc, Major Products and Services 9

RegenxBio Inc, History 10

RegenxBio Inc, Subsidiaries 12

RegenxBio Inc, Key Competitors 20

RegenxBio Inc, Ratios based on current share price 21

RegenxBio Inc, Annual Ratios 22

RegenxBio Inc, Annual Ratios (Cont...1) 23

RegenxBio Inc, Interim Ratios 25

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

RegenxBio Inc, Recent Deals Summary 29

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

RegenxBio Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

UniQure NV

Spark Therapeutics Inc

Shire Plc

Sangamo Therapeutics Inc

Regeneron Pharmaceuticals Inc

Kastle Therapeutics LLC

Genzyme Corp

Genentech Inc

bluebird bio Inc

BioMarin Pharmaceutical Inc

Applied Genetic Technologies Corp

Amgen Inc

Aegerion Pharmaceuticals Inc

Abeona Therapeutics Inc

RegenxBio Inc (RGNX) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

RegenxBio Inc (RegenxBio), formerly ReGenX Biosciences LLC is a provider of therapeutics for various diseases. The company develops, commercializes and licenses recombinant adeno associated virus (AAV) gene therapy. Its products include AAV plasmids, AAV vector reporter systems and custom AAV vectors. RegenxBio employs its proprietary NAV technology platform, a gene delivery technology to develop product candidates. The company offers products for metabolic, muscle, hematologic, ocular and neurodegenerative disorders. Its products find application in the areas of gene therapy, gene modulation, protein therapeutics, genetic vaccines and protein screening. RegenxBio is headquartered in Rockville, Maryland, the US.

RegenxBio Inc Key Recent Developments

May 29,2018: REGENXBIO Names Alexandra Glucksmann As Board Director

May 15,2018: REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation

May 08,2018: REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights

Apr 23,2018: Groundbreaking Research for Inherited Retinal Diseases Funded by Foundation Fighting Blindness to be Showcased at ARVO

Mar 06,2018: REGENXBIO Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 About the Company 6

RegenxBio Inc Key Facts 6

RegenxBio Inc Key Employees 7

RegenxBio Inc Key Employee Biographies 8

RegenxBio Inc Major Products and Services 9

RegenxBio Inc History 10

RegenxBio Inc Company Statement 11

RegenxBio Inc Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2 Company Analysis 13

Company Overview 13

RegenxBio Inc Business Description 14

R&D Overview 14

RegenxBio Inc Corporate Strategy 15

RegenxBio Inc SWOT Analysis 16

SWOT Analysis Overview 16

RegenxBio Inc Strengths 16

RegenxBio Inc Weaknesses 17

RegenxBio Inc Opportunities 18

RegenxBio Inc Threats 19

RegenxBio Inc Key Competitors 20

Section 3 Company Financial Ratios 21

Financial Ratios Capital Market Ratios 21

Financial Ratios Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios Interim Ratios 25

Financial Ratios Ratio Charts 26

Section 4 Company's, Lifesciences Financial Deals and Alliances 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

RegenxBio Inc, Recent Deals Summary 29

Section 5 Company's Recent Developments 30

May 15, 2018: REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation 30

May 08, 2018: REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights 31

Apr 23, 2018: Groundbreaking Research for Inherited Retinal Diseases Funded by Foundation Fighting Blindness to be Showcased at ARVO 33

Mar 06, 2018: REGENXBIO Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Highlights 35

Jan 04, 2018: REGENXBIO Provides Year End 2017 Corporate Update 37

Nov 08, 2017: REGENXBIO Reports Third Quarter 2017 Financial Results and Recent Operational Highlights 40

Aug 08, 2017: REGENXBIO Reports Second Quarter 2017 Financial Results and Recent Operational Highlights 42

May 09, 2017: REGENXBIO Reports First Quarter 2017 Financial Results and Recent Operational Highlights 44

Mar 28, 2017: REGENXBIO Enhances and Expands Scientific Leadership 46

Mar 07, 2017: REGENXBIO Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Highlights 47

Section 6 Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

RegenxBio Inc, Performance Chart (2013 2017) 24

RegenxBio Inc, Ratio Charts 26

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28


List Of Table

List of Tables

RegenxBio Inc, Key Facts 6

RegenxBio Inc, Key Employees 7

RegenxBio Inc, Key Employee Biographies 8

RegenxBio Inc, Major Products and Services 9

RegenxBio Inc, History 10

RegenxBio Inc, Subsidiaries 12

RegenxBio Inc, Key Competitors 20

RegenxBio Inc, Ratios based on current share price 21

RegenxBio Inc, Annual Ratios 22

RegenxBio Inc, Annual Ratios (Cont...1) 23

RegenxBio Inc, Interim Ratios 25

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

RegenxBio Inc, Recent Deals Summary 29

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

RegenxBio Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

UniQure NV

Spark Therapeutics Inc

Shire Plc

Sangamo Therapeutics Inc

Regeneron Pharmaceuticals Inc

Kastle Therapeutics LLC

Genzyme Corp

Genentech Inc

bluebird bio Inc

BioMarin Pharmaceutical Inc

Applied Genetic Technologies Corp

Amgen Inc

Aegerion Pharmaceuticals Inc

Abeona Therapeutics Inc